Key Metrics 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Benzo Petro International Ltd (524737)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524737 NSE: Chemicals | Small Cap | Benzo Petro Internl. Share Price
BSE Share Price
Not Listed
Not Listed
Benzo Petro International Ltd (524737)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524737 NSE: Chemicals | Small Cap | Benzo Petro Internl. Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹1 Cr.
Current Price
₹0
52-Week Low / High
₹1 / 1
TTM EPS
₹0
TTM Sales
₹43.2 Cr.
Book Value per Share
₹10.3
P/E Ratio
68.68
Industry PE
52.9
Price to Book (P/B)
0.13
Price to Sales (P/S)
0.03
EV/EBITDA
479.74
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
-1.19%
Return on Assets (ROA)
-5.16%
Operating Profit Margin
-0.4%
Net Profit Margin
-7.95%
Gross Profit Margin
-6.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
29.09%
Operating Profit Growth (1 Year)
-
-125%
Net Profit Growth (1 Year)
-
-868.75%
Asset Quality
Promoter Holding
17.70%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹11.1 Cr.
Face Value
₹10
All Time Low / High
₹0.30 / 14.50
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -2.1% | -18.8% | -69.3% | -6.5% | -13.5% | -16.3% | -101.6% | 33.6% | 17.6% | -1.2% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 3.1 | 1.1 | 0.5 | 12.8 | 28 | 28.6 | 35.2 | 106 | 71.9 | 92.8 | 43 |
| Sales YoY Gr. | - | -63.6% | -53.5% | 2,320.8% | 118.3% | 2.1% | 23% | 200.8% | -32.1% | 29.1% | - |
| Adj EPS ⓘ | -0.4 | -1.7 | -4.3 | -0.2 | -0.7 | -0.3 | -2.4 | 0.1 | 0.7 | -7 | 0 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | 407.7% | -1166.7% | - |
| BVPS (₹) ⓘ | 8.7 | 6.9 | 2.7 | 2.5 | 1.8 | 1.5 | -0.9 | 0.5 | 1.4 | -5.2 | 10.3 |
| Adj Net Profit ⓘ | -0.5 | -1.9 | -4.8 | -0.3 | -0.7 | -0.3 | -2.7 | 0.1 | 0.7 | -7.8 | 0 |
| Cash Flow from Ops. ⓘ | 0 | 0.1 | -1.6 | 0.4 | 2.4 | 5.7 | 0.5 | 7.6 | 1 | 13.4 | - |
| Debt/CF from Ops. ⓘ | 61.8 | 13.2 | -0.8 | 1.3 | 0.1 | 0 | 8.2 | 0.6 | 57.1 | 3.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 45.7% | 27.1% | 38.2% | 29.1% | ||||
| Adj EPS ⓘ | NA | NA | NA | -1166.7% | ||||
| BVPSⓘ | -194.5% | -223.5% | NA | -470.9% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -4.2 | -20.4 | -80.4 | -7.6 | -25.2 | -13 | -229.3 | 31.4 | 46.4 | 475.5 | 0.8 |
| Op. Profit Mgn % ⓘ | 0.8 | -164.4 | -862.7 | 0.2 | 0.6 | 0.8 | -4.8 | 0.5 | 3.2 | -0.4 | -1.5 |
| Net Profit Mgn % ⓘ | -14.4 | -166.9 | -901.9 | -2 | -2.6 | -1.2 | -7.6 | 0.1 | 1 | -8.4 | 0.1 |
| Debt to Equity ⓘ | 0.2 | 0.2 | 0.4 | 0.2 | 0.1 | 0 | -4.1 | 8.2 | 35.9 | -8.8 | - |
| Working Cap Days ⓘ | 680 | 1,519 | 1,482 | 34 | 47 | 121 | 165 | 134 | 475 | 472 | 94,512 |
| Cash Conv. Cycle ⓘ | 172 | 421 | 333 | 17 | -21 | -25 | 9 | 12 | 44 | 43 | -550 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.13 | 1.14 | 0.53 | 12.83 | 28.01 | 28.60 | 35.17 | 105.79 | 71.88 | 92.79 |
| Operating Expenses ⓘ + | 3.10 | 3.32 | 5.11 | 12.81 | 27.83 | 28.42 | 36.85 | 105.26 | 69.60 | 93.36 |
| Operating Profit ⓘ | 0.03 | -2.18 | -4.58 | 0.02 | 0.18 | 0.18 | -1.68 | 0.53 | 2.28 | -0.57 |
| Operating Profit Margin (%) | 0.8% | -191.0% | -868.0% | 0.2% | 0.6% | 0.6% | -4.8% | 0.5% | 3.2% | -0.6% |
| Other Income ⓘ + | 0.03 | 0.56 | 0.29 | 0.01 | 0.03 | 0.13 | 0.13 | 2.54 | 4.88 | 1.62 |
| Interest ⓘ | 0.21 | 0.21 | 0.15 | 0.01 | 0.36 | 0.01 | 0 | 0.21 | 4.57 | 6.77 |
| Depreciation ⓘ | 0.30 | 0.27 | 0.27 | 0.27 | 0.57 | 0.65 | 1.12 | 1.60 | 1.63 | 1.64 |
| Profit Before Tax ⓘ | -0.45 | -2.10 | -4.72 | -0.26 | -0.73 | -0.35 | -2.67 | 1.26 | 0.96 | -7.38 |
| Tax ⓘ | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0 | 0 | 0 |
| Profit After Tax | -0.45 | -2.10 | -4.72 | -0.26 | -0.74 | -0.36 | -2.68 | 1.26 | 0.96 | -7.38 |
| PAT Margin (%) | -14.4% | -184.0% | -893.0% | -2.0% | -2.6% | -1.2% | -7.6% | 1.2% | 1.3% | -8.0% |
| Adjusted EPS (₹) | -0.4 | -1.9 | -4.3 | -0.2 | -0.7 | -0.3 | -2.4 | 1.1 | 0.9 | -6.7 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Valuation of Benzo Petro Internl. - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 10.39 | 8.27 | 3.57 | 3.30 | 2.56 | 2.21 | -0.47 | 1.09 | 2.05 | -5.33 | |
| Debt + | 1.48 | 1.38 | 1.23 | 0.52 | 0.25 | 0 | 4 | 4.83 | 55.97 | 51 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 0.77 | 0.25 | 0.22 | 0.28 | 7.81 | 4.60 | 10.41 | 43.21 | 45.98 | 24.98 | |
| Others Liabilities ⓘ | 1.09 | 0.73 | 0.61 | 1.72 | 0.29 | 17.11 | 18.58 | 31.45 | 45.84 | 65.75 | |
| Total Liabilities ⓘ | 13.73 | 10.63 | 5.63 | 5.83 | 10.91 | 23.92 | 32.52 | 80.59 | 149.84 | 136.40 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 4.97 | 4.33 | 3.54 | 3.45 | 3.23 | 3.87 | 13.40 | 13.49 | 11.80 | 16.76 | |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 1.01 | 5.03 | 0 | 0 | 0.25 | 4.72 | |
| Investments ⓘ | 1.78 | 1.76 | 0.71 | 0.05 | 0.05 | 0.05 | 0.05 | 7.31 | 7.31 | 0.05 | |
| Inventories | 0.68 | 0.18 | 0.05 | 1.13 | 2.40 | 3.56 | 8.82 | 14.38 | 27.41 | 28.27 | |
| Trade Receivables | 1.68 | 0.71 | 0.28 | 0.26 | 0.74 | 1.34 | 0.29 | 34.10 | 33.47 | 13.58 | |
| Cash Equivalents | 0.41 | 0.29 | 0.06 | 0.05 | 0.54 | 1.06 | 0.05 | 0.25 | 1.18 | 0.63 | |
| Others Assets ⓘ | 4.22 | 3.36 | 0.99 | 0.87 | 2.95 | 9.01 | 9.91 | 11.06 | 68.41 | 72.39 | |
| Total Assets ⓘ | 13.73 | 10.63 | 5.63 | 5.83 | 10.91 | 23.92 | 32.52 | 80.59 | 149.84 | 136.40 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0.02 | 0.10 | -1.59 | 0.40 | 2.44 | 5.72 | 0.49 | 7.60 | 0.98 | 13.37 |
| Cash Flow From Investing Activity ⓘ + | -0.05 | 0.10 | 1.65 | 0.29 | -1.33 | -4.94 | -5.49 | -8.95 | -0.17 | -2.18 |
| Cash Flow From Financing Activity ⓘ + | 0.06 | -0.32 | -0.30 | -0.70 | -0.63 | -0.25 | 4 | 1.55 | 0.12 | -11.74 |
| Net Cash Flow ⓘ | 0.03 | -0.12 | -0.23 | -0.01 | 0.48 | 0.52 | -1.01 | 0.20 | 0.93 | -0.55 |
Financial Ratio
| PARTICULARS | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -4.54 | -24.33 | -89.29 | -9.19 | -31.17 | -19.41 | N/A | 0 | 88.88 | N/A |
| ROCE (%) | -2.13 | -18.78 | -69.32 | -6.54 | -13.48 | -16.29 | N/A | 33.62 | 17.55 | N/A |
| Asset Turnover Ratio | 0.23 | 0.09 | 0.06 | 2.24 | 3.35 | 1.64 | 1.25 | 1.87 | 0.63 | 0.66 |
| PAT to CFO Conversion(x) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 6.03 | 1.02 | N/A |
| Working Capital Days | ||||||||||
| Receivable Days | 175.60 | 383 | 340 | 7.60 | 6.60 | 13.30 | 8.40 | 59.30 | 170.70 | 91.50 |
| Inventory Days | 82.40 | 138.40 | 79.50 | 16.80 | 23 | 38 | 64.20 | 40 | 105.60 | 108.30 |
| Payable Days | 138.10 | 204.60 | 404.10 | 7.70 | 55.50 | 84.30 | 81.20 | 95.20 | 245.10 | 146.10 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Benzo Petro International Ltd FAQs
The current trading price of Benzo Petro Internl. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Benzo Petro Internl. stood at ₹1.44 Cr
The latest P/E ratio of Benzo Petro Internl. as of 31-Dec-1969 is 68.68.
The latest P/B ratio of Benzo Petro Internl. as of 31-Dec-1969 is 0.13.
The 52-week high of Benzo Petro Internl. is ₹1.30 and the 52-week low is ₹1.30.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Benzo Petro Internl. is ₹43.20 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Benzo Petro International Ltd
Benzo Petro International Limited was incorporated on September 18, 1991. The company is promoted by technocrat promoters from GAMI FAMILY comprising of D.C. Gami and Ramesh C. Gami along with Benzo Petrochemicals Ltd., a Public Limited Company within the group, as a Co-promoter. In the general body meeting of Benzo Petrochemicals Limited, held on September 30, 1992 the resolution was passed approving the participation of BPL in the project.
Present Business of the company
The company has developed technology for the production of all the products viz. Chloro Toluenes, Ortho Chloro Benzaldehyde and 2 Acetyl 6 Methocy Naphthalene through KCPL initially on a laboratory scale and subsequently on pilot plant scale. The process for N26 is fully developed, plant designed and equipment procured and installed and manufacturing and marketing of the product started. The Company has also received as firm order for export of N26 worth $ 348,000 (Equivalent to Rs 109, 62,000). This order is to be executed in twelve months starting from November 1994. The Company has also developed the processes for the production of Ortho Chloro Benzoic Acid, Para Chloro Benzyl Cyanide and Para Chloro Benzaldehyde through their consultants, M/s KCPL, and have already started production and marketing of one of the products, Ortho Chloro Benzoic Acid.
The technologies for Chloro Toluenes and OCB have been developed on laboratory scale and pilot plant scale. The sample of mixture of OCT/PCT produced at the pilot plant scale has been sent to Bhabha Atomic Research Centre, Bombay for analysis and the report was found satisfactory.
Basis design work of the plant is completed and detailed engineering work has started. Procurement of equipment has started. Orders for all items with long terms deliveries are placed. It is expected that all the machinery will be received at site.
Process for OCB is also stabilized and the Company has established production facilities for production of Ortho Chloro Benzaldehyde by importing the basic raw material, Ortho Chloro Toluene. The Company started selling OCB since May, 1994. It has received firm order for supply of 5 MTs OCB from Chem Ace marketing, Delhi.
Products
• CMIC Chloride
• DCMIC Chloride
• FCMIC Chloride
• Para Chloro Benzaldehyde
• Ortho Chloro Benzaldehyde
• Ortho Chloro Benzo Nirile
• Ortho Chloro Benzo Amine
• Ortho Sulphonic Benzaldehyde (BOSS)
Present Business of the company
The company has developed technology for the production of all the products viz. Chloro Toluenes, Ortho Chloro Benzaldehyde and 2 Acetyl 6 Methocy Naphthalene through KCPL initially on a laboratory scale and subsequently on pilot plant scale. The process for N26 is fully developed, plant designed and equipment procured and installed and manufacturing and marketing of the product started. The Company has also received as firm order for export of N26 worth $ 348,000 (Equivalent to Rs 109, 62,000). This order is to be executed in twelve months starting from November 1994. The Company has also developed the processes for the production of Ortho Chloro Benzoic Acid, Para Chloro Benzyl Cyanide and Para Chloro Benzaldehyde through their consultants, M/s KCPL, and have already started production and marketing of one of the products, Ortho Chloro Benzoic Acid.
The technologies for Chloro Toluenes and OCB have been developed on laboratory scale and pilot plant scale. The sample of mixture of OCT/PCT produced at the pilot plant scale has been sent to Bhabha Atomic Research Centre, Bombay for analysis and the report was found satisfactory.
Basis design work of the plant is completed and detailed engineering work has started. Procurement of equipment has started. Orders for all items with long terms deliveries are placed. It is expected that all the machinery will be received at site.
Process for OCB is also stabilized and the Company has established production facilities for production of Ortho Chloro Benzaldehyde by importing the basic raw material, Ortho Chloro Toluene. The Company started selling OCB since May, 1994. It has received firm order for supply of 5 MTs OCB from Chem Ace marketing, Delhi.
Products
• CMIC Chloride
• DCMIC Chloride
• FCMIC Chloride
• Para Chloro Benzaldehyde
• Ortho Chloro Benzaldehyde
• Ortho Chloro Benzo Nirile
• Ortho Chloro Benzo Amine
• Ortho Sulphonic Benzaldehyde (BOSS)
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
